Importantly, a decrease in ACE-2 activity in some COVID-19 comorbidities, such as hypertension and DMT2, may be related to a high degree of genetic polymorphism in the ACE-2 gene (Sayed, 2021). Here, ACE2 is linked to COVID-19.